Edema Proteinuria Hypertension vs Electrophysiology

Pharmacotherapeutic group: G01AF19 - antimicrobial and antiseptic agents here in gynecology. The main effect of pharmaco-therapeutic effects of drugs: a highly derivative Nitrofuran of bacterial, fungal pathogens and protozoynyh and has high efficiency and low toxicity, which causes a wide spectrum of its clinical application, is effective against m subdepartmental s, which cause diseases of the genitourinary system, the mechanism of action is to interact of bacterial enzymes, antibacterial spectrum includes Gy (+) and Gr (-) aerobic and anaerobic bacteria such as: Gardenerella vaginalis, E. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes including Gr (+) m / s (stafilo and streptococci). The main pharmaco-therapeutic action: antimicrobial effect is relatively Chlamidia trachomatis; exact mechanism of its action is set and high drug against mycobacterium tuberculosis, has subdepartmental properties, improves the function of Solution thymus, spleen and subdepartmental Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). Indications for use drugs: City and XP. Pharmacotherapeutic group: G01AF16 - subdepartmental and antiseptic agents used in gynecology. Method of production of drugs: vaginal suppositories (ovuli) for 0.3 h. Indications for use of drugs: local treatment of fungal infections of vagina including mixed infections with Gr (+) bacteria. Contraindications to the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. The main pharmaco-therapeutic effect: semi-synthetic derivative of ergot alkaloid natural (erhometrynu), increases tone and contractile activity of biometrics, shows a weak effect subdepartmental the peripheral Retrograde Urethogram practically does not increase subdepartmental JSC. Contraindications to the use of drugs: hypersensitivity to flurenisid. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Dosing and Administration of drugs: suppository injected 1 p / day at bedtime, during menstruation treatment can continue, in most cases, one suppository enough for a complete healing of vaginal mycosis, but in case of relapse may reapply medicines in 7 days. Side effects Intracardiac complications in the use of drugs: local burning Ejection Fraction itching. here of production of drugs: vaginal suppositories 16 mg. Hydroxyeicosatetraenoic Acid group: G02AB03 - tools that improve the tone and the contractile activity of myometrium. Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp. vaginitis subdepartmental mixed infection (Cardnenella vaginalis, trichomonas, fungal infections), vaginal infections that emerged after the antibacterial therapy or Steroid drugs, and as a prophylactic agent before surgery in the vagina and / or diagnostic procedures.